NCT04135521View on ClinicalTrials.gov

Dose-dense Chemotherapy Versus Intraperitoneal Chemotherapy as First-line Chemotherapy in Advanced Ovarian Cancer

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

October 28, 2019

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2020

Conditions
Advanced Ovarian Cancer
Interventions
DRUG

Intraperitoneal chemotherapy

Intraperitoneal or intravenous dose-dense platinum/taxane chemotherapy

Trial Locations (1)

22050

Department of Obstetrics and Gynecology, Far-Eastern Memorial Hospital, Banqiao District

All Listed Sponsors
lead

Far Eastern Memorial Hospital

OTHER

NCT04135521 - Dose-dense Chemotherapy Versus Intraperitoneal Chemotherapy as First-line Chemotherapy in Advanced Ovarian Cancer | Biotech Hunter | Biotech Hunter